Annual EBITDA
-$24.36 M
+$8.99 M+26.96%
December 31, 2023
Summary
- As of February 7, 2025, CDTX annual EBITDA is -$24.36 million, with the most recent change of +$8.99 million (+26.96%) on December 31, 2023.
- During the last 3 years, CDTX annual EBITDA has risen by +$46.43 million (+65.59%).
- CDTX annual EBITDA is now -2151.85% below its all-time high of -$1.08 million, reached on December 31, 2013.
Performance
CDTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$17.33 M
-$6.29 M-56.94%
September 30, 2024
Summary
- As of February 7, 2025, CDTX quarterly EBITDA is -$17.33 million, with the most recent change of -$6.29 million (-56.94%) on September 30, 2024.
- Over the past year, CDTX quarterly EBITDA has dropped by -$11.25 million (-184.85%).
- CDTX quarterly EBITDA is now -215.86% below its all-time high of $14.96 million, reached on September 30, 2022.
Performance
CDTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$45.10 M
-$12.89 M-40.01%
September 30, 2024
Summary
- As of February 7, 2025, CDTX TTM EBITDA is -$45.10 million, with the most recent change of -$12.89 million (-40.01%) on September 30, 2024.
- Over the past year, CDTX TTM EBITDA has dropped by -$30.66 million (-212.28%).
- CDTX TTM EBITDA is now -7967.44% below its all-time high of -$559.00 thousand, reached on March 31, 2014.
Performance
CDTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CDTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.0% | -184.8% | -212.3% |
| 3 y3 years | +65.6% | -716.2% | -264.8% |
| 5 y5 years | +61.2% | -716.2% | -264.8% |
CDTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.3% | -215.9% | +3.5% | -655.0% | +31.3% |
| 5 y | 5-year | at high | +65.6% | -215.9% | +16.2% | -655.0% | +39.3% |
| alltime | all time | -2151.8% | +65.6% | -215.9% | +16.2% | -7967.4% | +39.3% |
Cidara Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$17.33 M(+56.9%) | -$45.10 M(+40.0%) |
| Jun 2024 | - | -$11.04 M(+3.8%) | -$32.21 M(+15.5%) |
| Mar 2024 | - | -$10.63 M(+74.8%) | -$27.89 M(+93.1%) |
| Dec 2023 | -$24.36 M(-27.0%) | -$6.08 M(+36.9%) | -$14.44 M(-43.1%) |
| Sep 2023 | - | -$4.45 M(-33.9%) | -$25.38 M(+324.9%) |
| Jun 2023 | - | -$6.72 M(-339.0%) | -$5.97 M(-51.7%) |
| Mar 2023 | - | $2.81 M(-116.5%) | -$12.36 M(-62.7%) |
| Dec 2022 | -$33.36 M(-21.1%) | -$17.02 M(-213.8%) | -$33.14 M(+0.8%) |
| Sep 2022 | - | $14.96 M(-214.1%) | -$32.89 M(-49.9%) |
| Jun 2022 | - | -$13.11 M(-27.0%) | -$65.59 M(+58.3%) |
| Mar 2022 | - | -$17.96 M(+7.1%) | -$41.44 M(+0.0%) |
| Dec 2021 | -$42.26 M(-40.3%) | -$16.77 M(-5.5%) | -$41.43 M(-8.6%) |
| Sep 2021 | - | -$17.74 M(-260.7%) | -$45.35 M(+0.6%) |
| Jun 2021 | - | $11.04 M(-161.5%) | -$45.07 M(-39.3%) |
| Mar 2021 | - | -$17.96 M(-13.2%) | -$74.26 M(+4.9%) |
| Dec 2020 | -$70.80 M(+69.7%) | -$20.68 M(+18.4%) | -$70.80 M(+10.3%) |
| Sep 2020 | - | -$17.46 M(-3.8%) | -$64.20 M(+47.1%) |
| Jun 2020 | - | -$18.15 M(+25.2%) | -$43.63 M(+10.0%) |
| Mar 2020 | - | -$14.50 M(+3.0%) | -$39.68 M(-4.2%) |
| Dec 2019 | -$41.72 M | -$14.08 M(-553.9%) | -$41.42 M(-5.5%) |
| Sep 2019 | - | $3.10 M(-121.9%) | -$43.83 M(-28.8%) |
| Jun 2019 | - | -$14.20 M(-12.6%) | -$61.52 M(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$16.25 M(-1.5%) | -$62.34 M(-0.7%) |
| Dec 2018 | -$62.76 M(+14.0%) | -$16.49 M(+13.0%) | -$62.76 M(+5.3%) |
| Sep 2018 | - | -$14.59 M(-2.9%) | -$59.59 M(+4.3%) |
| Jun 2018 | - | -$15.02 M(-9.9%) | -$57.11 M(-2.4%) |
| Mar 2018 | - | -$16.67 M(+25.2%) | -$58.52 M(+6.3%) |
| Dec 2017 | -$55.05 M(+15.4%) | -$13.32 M(+10.0%) | -$55.05 M(-1.5%) |
| Sep 2017 | - | -$12.11 M(-26.3%) | -$55.90 M(-0.1%) |
| Jun 2017 | - | -$16.43 M(+24.5%) | -$55.95 M(+9.3%) |
| Mar 2017 | - | -$13.20 M(-6.8%) | -$51.20 M(+7.3%) |
| Dec 2016 | -$47.70 M(+49.8%) | -$14.17 M(+16.5%) | -$47.70 M(+10.2%) |
| Sep 2016 | - | -$12.16 M(+4.2%) | -$43.29 M(+7.6%) |
| Jun 2016 | - | -$11.67 M(+20.3%) | -$40.24 M(+15.2%) |
| Mar 2016 | - | -$9.71 M(-0.5%) | -$34.92 M(+9.6%) |
| Dec 2015 | -$31.85 M(+223.8%) | -$9.76 M(+7.1%) | -$31.85 M(+19.5%) |
| Sep 2015 | - | -$9.11 M(+43.5%) | -$26.66 M(+28.2%) |
| Jun 2015 | - | -$6.35 M(-4.4%) | -$20.80 M(+30.6%) |
| Mar 2015 | - | -$6.64 M(+45.7%) | -$15.92 M(+61.8%) |
| Dec 2014 | -$9.84 M(+809.1%) | -$4.56 M(+40.3%) | -$9.84 M(+86.4%) |
| Sep 2014 | - | -$3.25 M(+121.2%) | -$5.28 M(+160.3%) |
| Jun 2014 | - | -$1.47 M(+162.8%) | -$2.03 M(+262.8%) |
| Mar 2014 | - | -$559.00 K | -$559.00 K |
| Dec 2013 | -$1.08 M | - | - |
FAQ
- What is Cidara Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Cidara Therapeutics?
- What is Cidara Therapeutics annual EBITDA year-on-year change?
- What is Cidara Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Cidara Therapeutics?
- What is Cidara Therapeutics quarterly EBITDA year-on-year change?
- What is Cidara Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Cidara Therapeutics?
- What is Cidara Therapeutics TTM EBITDA year-on-year change?
What is Cidara Therapeutics annual EBITDA?
The current annual EBITDA of CDTX is -$24.36 M
What is the all time high annual EBITDA for Cidara Therapeutics?
Cidara Therapeutics all-time high annual EBITDA is -$1.08 M
What is Cidara Therapeutics annual EBITDA year-on-year change?
Over the past year, CDTX annual EBITDA has changed by +$8.99 M (+26.96%)
What is Cidara Therapeutics quarterly EBITDA?
The current quarterly EBITDA of CDTX is -$17.33 M
What is the all time high quarterly EBITDA for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly EBITDA is $14.96 M
What is Cidara Therapeutics quarterly EBITDA year-on-year change?
Over the past year, CDTX quarterly EBITDA has changed by -$11.25 M (-184.85%)
What is Cidara Therapeutics TTM EBITDA?
The current TTM EBITDA of CDTX is -$45.10 M
What is the all time high TTM EBITDA for Cidara Therapeutics?
Cidara Therapeutics all-time high TTM EBITDA is -$559.00 K
What is Cidara Therapeutics TTM EBITDA year-on-year change?
Over the past year, CDTX TTM EBITDA has changed by -$30.66 M (-212.28%)